Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in JAK2 V617F Positive Polycythemia Vera
NCT01038856Phase 2Terminated
- Sponsor
- University of Oklahoma
- Start
- Dec 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in polycythemia vera (PV), sponsored by University of Oklahoma. Started Dec 2009; status: terminated.
02
Drugs
erlotinib
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT01038856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038856.